USD 9.3 Billion in 2024, USD 46.62 Billion by 2035. CRISPR holds 67.5% by 2034. Vertex sales: $625 million. China: $5.5 billion allocated in 2024. U.S.: $3.13 billion in 2024, $14.82 billion by 2034. pharmiweb.com/press-release/…

Jennifer Doudna helped discover CRISPR in 2011. She won the 2020 Nobel Prize in Chemistry. Doudna leads the Doudna Lab. Customized CRISPR treatments offer hope for genetic disorders. vpm.org/npr-news/2025-…

Valued USD 3.65B in 2024; expected USD 12.6B by 2034. globenewswire.com/news-release/2…

Affects 10 million people [1]; 15 of 22 corneal dystrophies gene therapy amenable [9]. Choi EH, Suh S: Genome editing in ocular diseases [2023]. Jiang F, Doudna JA: CRISPR-Cas9 mechanisms [2017]. Wei A: In vivo CRISPR editing herpetic keratitis [2023]. nature.com/articles/s4143…

Leader: Melissa Deck. Methods: CRISPR/Cas9, LNP, AAV. Vaccines: Pfizer-BioNTech's BNT162b2, Moderna's mRNA-1273. Therapies approved: Patisiran, Givosiran, Eteplirsen, Nusinersen. Companies: Pfizer, Moderna, Liberate Bio, Quantum-Si. technologynetworks.com/tn/blog/overco…

In 2017, Time magazine named him as one of the 100 most influential people in the world. He has co-founded over 50 biotech startups through his lab at Harvard. wyss.harvard.edu/media-post/geo…

$1.3B Eli Lilly-Verve deal; VERVE-102 base editing; 53% LDL reduction; $200B cholesterol market; $1B upfront, $300M Phase 3 CVR; VERVE-102 Phase 3 by 2035. ainvest.com/news/eli-lilly…

IDLV-mediated gene editing for MPS IVA. researchgate.net/figure/Correct…

FDA investigates death of 8-year-old in Brazil after Elevidys treatment. Sarepta voluntarily pauses Elevidys shipments in the U.S. FDA requests black box warning for liver issues on Elevidys label. genengnews.com/topics/genome-…

Genome-edited rice varieties DRR Dhan 100 and Pusa Rice DST 1, developed by public-sector with CRISPR-cas9, boost yield by 25-30% and circumvent commercial IPRs. Govt allocated Rs 486 crore since 2020. Potential replacement for 9 MHa varieties. financialexpress.com/india-news/pub…

N/A postguam.com/forum/featured…

Prof. Jack Heinemann's paper used against the Gene Tech Bill. Dr. William Rolleston criticizes speculative claims in regulatory discussions. geneticliteracyproject.org/2025/07/28/dis…

Osaka University researchers designed a gene editing strategy enabling mice to produce Exenatide in liver cells, aiding weight loss and glucose control. labmate-online.com/news/laborator…

13.5% of arable land has GM crops. Colossal aims to recreate woolly mammoth. Colossal engineered gray wolf with 20 gene edits. Cock van Oosterhout et al published a paper in Nature Reviews Biodiversity. phys.org/news/2025-07-g…

In 2023, the market size was $7.20 billion. Expected growth to $6,739.8 million by 2028. CAGR from 2022 to 2023 is 17.8%. openpr.com/news/4122622/g…

Prime Medicine focuses on Wilson's Disease and AATD, showing 72% gene correction in tests. Collaborates with Cystic Fibrosis Foundation for $24M funding. investing.com/news/swot-anal…

CRISPR-GPT knocked out 4 genes in a lung cancer line. Princeton and Stanford filed patent 19/093,928 by 2025. nature.com/articles/s4155…

CRISPR-Cas9, TALENs, and base editors are in demand for therapeutics. Aging population needs scalable editing platforms for genetic disorders. R&D and supportive policies boost Japan's genome editing market. globenewswire.com/news-release/2…

Shandong Agricultural University published findings on gene CrAUX/IAA20 affecting petal shape using T2T genomic assembly and auxin regulation. Gene editing for floral design is proposed. newswise.com/articles/petal…

PE7 outperforms PEmax, enhanced in cell editing efficiency. PE2 shows up to 51.7% efficiency with SpRY variant for genome sites. nature.com/articles/s1227…